HRS/ACC/AHA Expert Consensus Statement on the Use of ICD Therapy in Patients...

Updated:Dec 15,2014
AHA Science News

HRS/ACC/AHA Expert Consensus Statement on the Use of ICD Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials


  • The use of implantable cardioverter-defibrillator (ICD) therapy is a widely accepted and important treatment for patients with cardiovascular disease who are at risk for life-threatening ventricular arrhythmias.
  • Situations still exist that aren’t addressed by existing guidelines, which are limited to those specific populations in the trials included in those guidelines.
  • This joint consensus statement helps identify those patients who will receive optimal benefit from the timely use of ICD therapy.

    Read the full article in Circulation
    [published online ahead of print May 9, 2014]. Circulation. doi: 10.1161/CIR.0000000000000056.

Supporting Materials  
Other Resources
Related Science 

Did you see these recent Commentaries?

Commentaries View All

Connect with AHA Science News

Follow AHAScience on Twitter (opens in new window)
Like AHA Science News on Facebook (opens in new window)

Science Volunteer Opportunities

AHA Volunteer Opportunities. Complete the Science Volunteer Involvement Form.

Science News View All

Professional Online Network

Connect with over 30,000 heart and stroke professionals.